SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015790
Filing Date
2023-04-28
Accepted
2023-04-28 16:09:27
Documents
6
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2023_bolt_def_14a.htm DEF 14A 1290649
2 GRAPHIC img49983226_0.jpg GRAPHIC 16109
3 GRAPHIC img49983226_1.jpg GRAPHIC 1412130
4 GRAPHIC img49983226_2.jpg GRAPHIC 722306
5 GRAPHIC img49983226_3.jpg GRAPHIC 1638439
6 GRAPHIC img49983226_4.jpg GRAPHIC 408227
  Complete submission text file 0000950170-23-015790.txt   7071080
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39988 | Film No.: 23866114
SIC: 2834 Pharmaceutical Preparations